These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 11132243)

  • 1. Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds.
    Richelson E; Souder T
    Life Sci; 2000 Nov; 68(1):29-39. PubMed ID: 11132243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding.
    Schotte A; Janssen PF; Gommeren W; Luyten WH; Van Gompel P; Lesage AS; De Loore K; Leysen JE
    Psychopharmacology (Berl); 1996 Mar; 124(1-2):57-73. PubMed ID: 8935801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical antipsychotics: mechanism of action.
    Seeman P
    Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of serotonin 5-HT2C and histamine H1 receptors in antipsychotic-induced diabetes: A pharmacoepidemiological-pharmacodynamic study in VigiBase.
    Montastruc F; Palmaro A; Bagheri H; Schmitt L; Montastruc JL; Lapeyre-Mestre M
    Eur Neuropsychopharmacol; 2015 Oct; 25(10):1556-65. PubMed ID: 26256010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of antidepressants to human brain receptors: focus on newer generation compounds.
    Cusack B; Nelson A; Richelson E
    Psychopharmacology (Berl); 1994 May; 114(4):559-65. PubMed ID: 7855217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity.
    Leysen JE; Janssen PM; Megens AA; Schotte A
    J Clin Psychiatry; 1994 May; 55 Suppl():5-12. PubMed ID: 7520908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography.
    Schotte A; Janssen PF; Megens AA; Leysen JE
    Brain Res; 1993 Dec; 631(2):191-202. PubMed ID: 7510574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor occupancy-based analysis of the contributions of various receptors to antipsychotics-induced weight gain and diabetes mellitus.
    Matsui-Sakata A; Ohtani H; Sawada Y
    Drug Metab Pharmacokinet; 2005 Oct; 20(5):368-78. PubMed ID: 16272755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing sertindole to other new generation antipsychotics on preferential dopamine output in limbic versus striatal projection regions: mechanism of action.
    Hertel P
    Synapse; 2006 Dec; 60(7):543-52. PubMed ID: 16952163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of serotonin in the action of atypical antipsychotic drugs.
    Meltzer HY
    Clin Neurosci; 1995; 3(2):64-75. PubMed ID: 7583621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.
    Seeger TF; Seymour PA; Schmidt AW; Zorn SH; Schulz DW; Lebel LA; McLean S; Guanowsky V; Howard HR; Lowe JA
    J Pharmacol Exp Ther; 1995 Oct; 275(1):101-13. PubMed ID: 7562537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin receptors: their key role in drugs to treat schizophrenia.
    Meltzer HY; Li Z; Kaneda Y; Ichikawa J
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1159-72. PubMed ID: 14642974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asenapine: a novel psychopharmacologic agent with a unique human receptor signature.
    Shahid M; Walker GB; Zorn SH; Wong EH
    J Psychopharmacol; 2009 Jan; 23(1):65-73. PubMed ID: 18308814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of serotonin in antipsychotic drug action.
    Meltzer HY
    Neuropsychopharmacology; 1999 Aug; 21(2 Suppl):106S-115S. PubMed ID: 10432496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical antipsychotic drugs, quetiapine, iloperidone, and melperone, preferentially increase dopamine and acetylcholine release in rat medial prefrontal cortex: role of 5-HT1A receptor agonism.
    Ichikawa J; Li Z; Dai J; Meltzer HY
    Brain Res; 2002 Nov; 956(2):349-57. PubMed ID: 12445705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonism by neuroleptics of neurotransmitter receptors of normal human brain in vitro.
    Richelson E; Nelson A
    Eur J Pharmacol; 1984 Aug; 103(3-4):197-204. PubMed ID: 6149136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regulation of rat 5-HT2A and 5-HT2C receptors after chronic treatment with clozapine, chlorpromazine and three putative atypical antipsychotic drugs.
    Kuoppamäki M; Pälvimäki EP; Hietala J; Syvälahti E
    Neuropsychopharmacology; 1995 Oct; 13(2):139-50. PubMed ID: 8597525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors.
    Seeman P; Corbett R; Van Tol HH
    Neuropsychopharmacology; 1997 Feb; 16(2):93-110; discussion 111-35. PubMed ID: 9015795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The psychopharmacology of ziprasidone: receptor-binding properties and real-world psychiatric practice.
    Stahl SM; Shayegan DK
    J Clin Psychiatry; 2003; 64 Suppl 19():6-12. PubMed ID: 14728084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonism by antidepressants of neurotransmitter receptors of normal human brain in vitro.
    Richelson E; Nelson A
    J Pharmacol Exp Ther; 1984 Jul; 230(1):94-102. PubMed ID: 6086881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.